These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Safety and efficacy of neonatal vaccination. Demirjian A; Levy O Eur J Immunol; 2009 Jan; 39(1):36-46. PubMed ID: 19089811 [TBL] [Abstract][Full Text] [Related]
26. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease. Mortellaro A; Ricciardi-Castagnoli P Immunol Cell Biol; 2011 Mar; 89(3):332-9. PubMed ID: 21301476 [TBL] [Abstract][Full Text] [Related]
27. Immunosenescence and vaccine failure in the elderly. Grubeck-Loebenstein B; Della Bella S; Iorio AM; Michel JP; Pawelec G; Solana R Aging Clin Exp Res; 2009 Jun; 21(3):201-9. PubMed ID: 19571643 [TBL] [Abstract][Full Text] [Related]
28. [Vaccination of the elderly]. Cruz Jentoft AJ Rev Clin Esp; 1995 Sep; 195(9):595-7. PubMed ID: 7481000 [No Abstract] [Full Text] [Related]
29. Challenges in adult vaccination. de Gomensoro E; Del Giudice G; Doherty TM Ann Med; 2018 May; 50(3):181-192. PubMed ID: 29338438 [TBL] [Abstract][Full Text] [Related]
30. Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Van Loveren H; Van Amsterdam JG; Vandebriel RJ; Kimman TG; Rümke HC; Steerenberg PS; Vos JG Environ Health Perspect; 2001 Aug; 109(8):757-64. PubMed ID: 11564609 [TBL] [Abstract][Full Text] [Related]
31. Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity. Oh SJ; Lee JK; Shin OS Immune Netw; 2019 Dec; 19(6):e37. PubMed ID: 31921467 [TBL] [Abstract][Full Text] [Related]
32. Immunosenescence: Implications for response to infection and vaccination in older people. Pera A; Campos C; López N; Hassouneh F; Alonso C; Tarazona R; Solana R Maturitas; 2015 Sep; 82(1):50-5. PubMed ID: 26044074 [TBL] [Abstract][Full Text] [Related]
33. Immunity and ageing in man. Pawelec G Exp Gerontol; 2006 Dec; 41(12):1239-42. PubMed ID: 17118601 [TBL] [Abstract][Full Text] [Related]
34. Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity. Moore AC; Hutchings CL Expert Rev Vaccines; 2007 Feb; 6(1):111-21. PubMed ID: 17280483 [TBL] [Abstract][Full Text] [Related]
35. Novel Technologies to Improve Vaccines for Older Adults. Laupèze B; van der Most R; Del Giudice G Interdiscip Top Gerontol Geriatr; 2020; 43():218-233. PubMed ID: 32305970 [TBL] [Abstract][Full Text] [Related]
36. T cell immunostimulation by methyl inosine 5'-monophosphate: application to infectious diseases. Signorelli KL; Hadden JW Int Immunopharmacol; 2003 Aug; 3(8):1177-86. PubMed ID: 12860173 [TBL] [Abstract][Full Text] [Related]
37. Vaccine responsiveness in the elderly: best practice for the clinic. Aspinall R; Lang PO Expert Rev Vaccines; 2014 Jul; 13(7):885-94. PubMed ID: 24890875 [TBL] [Abstract][Full Text] [Related]
38. Synthetic vaccines: present and future. Arnon R; Sela M Ann Inst Pasteur Immunol (1985); 1985; 136D(3):271-82. PubMed ID: 3913380 [No Abstract] [Full Text] [Related]
39. Promoting life course vaccination. Michel JP; Lang PO Rejuvenation Res; 2011 Feb; 14(1):75-81. PubMed ID: 21208066 [TBL] [Abstract][Full Text] [Related]
40. Heterologous immunity and the nonspecific effects of vaccines: a major medical advance? Shann F Pediatr Infect Dis J; 2004 Jun; 23(6):555-8. PubMed ID: 15194839 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]